img

Global Veterinary Peptide Products Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Veterinary Peptide Products Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Veterinary Peptide Products Market
Global Veterinary Peptide Products market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Veterinary Peptide Products industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Veterinary Peptide Products key companies include AmbioPharm, Zoetis, Ceva Corporate, Huvepharma, Lifecome Biochemistry, Qilu Pharmaceutical, Orion Animal Nutrition, Vega Pharma and Tianjin Xinxing Veterinary Pharmaceutical, etc. AmbioPharm, Zoetis, Ceva Corporate are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Veterinary Peptide Products were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Veterinary Peptide Products market and estimated to attract more attentions from industry insiders and investors.
Veterinary Peptide Products can be divided into Oxytocin, Gonadorelin, Buserelin and Veterinary Bacitracin Zinc, etc. Oxytocin is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Veterinary Peptide Products is widely used in various fields, such as Pig, Ox, Sheep and Others, etc. Pig provides greatest supports to the Veterinary Peptide Products industry development. In 2022, global % revenue of Veterinary Peptide Products went into Pig filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Veterinary Peptide Products market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Veterinary Peptide Products market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


AmbioPharm
Zoetis
Ceva Corporate
Huvepharma
Lifecome Biochemistry
Qilu Pharmaceutical
Orion Animal Nutrition
Vega Pharma
Tianjin Xinxing Veterinary Pharmaceutical
Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
Segment by Type
Oxytocin
Gonadorelin
Buserelin
Veterinary Bacitracin Zinc
Others

Segment by Application


Pig
Ox
Sheep
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Veterinary Peptide Products introduction, etc. Veterinary Peptide Products Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Veterinary Peptide Products
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Peptide Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Oxytocin
1.2.3 Gonadorelin
1.2.4 Buserelin
1.2.5 Veterinary Bacitracin Zinc
1.2.6 Others
1.3 Market by Application
1.3.1 Global Veterinary Peptide Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pig
1.3.3 Ox
1.3.4 Sheep
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Peptide Products Market Perspective (2018-2033)
2.2 Global Veterinary Peptide Products Growth Trends by Region
2.2.1 Veterinary Peptide Products Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Veterinary Peptide Products Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Peptide Products Forecasted Market Size by Region (2024-2033)
2.3 Veterinary Peptide Products Market Dynamics
2.3.1 Veterinary Peptide Products Industry Trends
2.3.2 Veterinary Peptide Products Market Drivers
2.3.3 Veterinary Peptide Products Market Challenges
2.3.4 Veterinary Peptide Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Veterinary Peptide Products by Players
3.1.1 Global Veterinary Peptide Products Revenue by Players (2018-2023)
3.1.2 Global Veterinary Peptide Products Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Peptide Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Veterinary Peptide Products, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Veterinary Peptide Products Market Concentration Ratio
3.4.1 Global Veterinary Peptide Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Peptide Products Revenue in 2022
3.5 Global Key Players of Veterinary Peptide Products Head office and Area Served
3.6 Global Key Players of Veterinary Peptide Products, Product and Application
3.7 Global Key Players of Veterinary Peptide Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Peptide Products Breakdown Data by Type
4.1 Global Veterinary Peptide Products Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Peptide Products Forecasted Market Size by Type (2024-2033)
5 Veterinary Peptide Products Breakdown Data by Application
5.1 Global Veterinary Peptide Products Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Peptide Products Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Veterinary Peptide Products Market Size (2018-2033)
6.2 North America Veterinary Peptide Products Market Size by Type
6.2.1 North America Veterinary Peptide Products Market Size by Type (2018-2023)
6.2.2 North America Veterinary Peptide Products Market Size by Type (2024-2033)
6.2.3 North America Veterinary Peptide Products Market Share by Type (2018-2033)
6.3 North America Veterinary Peptide Products Market Size by Application
6.3.1 North America Veterinary Peptide Products Market Size by Application (2018-2023)
6.3.2 North America Veterinary Peptide Products Market Size by Application (2024-2033)
6.3.3 North America Veterinary Peptide Products Market Share by Application (2018-2033)
6.4 North America Veterinary Peptide Products Market Size by Country
6.4.1 North America Veterinary Peptide Products Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Veterinary Peptide Products Market Size by Country (2018-2023)
6.4.3 North America Veterinary Peptide Products Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Veterinary Peptide Products Market Size (2018-2033)
7.2 Europe Veterinary Peptide Products Market Size by Type
7.2.1 Europe Veterinary Peptide Products Market Size by Type (2018-2023)
7.2.2 Europe Veterinary Peptide Products Market Size by Type (2024-2033)
7.2.3 Europe Veterinary Peptide Products Market Share by Type (2018-2033)
7.3 Europe Veterinary Peptide Products Market Size by Application
7.3.1 Europe Veterinary Peptide Products Market Size by Application (2018-2023)
7.3.2 Europe Veterinary Peptide Products Market Size by Application (2024-2033)
7.3.3 Europe Veterinary Peptide Products Market Share by Application (2018-2033)
7.4 Europe Veterinary Peptide Products Market Size by Country
7.4.1 Europe Veterinary Peptide Products Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Veterinary Peptide Products Market Size by Country (2018-2023)
7.4.3 Europe Veterinary Peptide Products Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Veterinary Peptide Products Market Size (2018-2033)
8.2 China Veterinary Peptide Products Market Size by Type
8.2.1 China Veterinary Peptide Products Market Size by Type (2018-2023)
8.2.2 China Veterinary Peptide Products Market Size by Type (2024-2033)
8.2.3 China Veterinary Peptide Products Market Share by Type (2018-2033)
8.3 China Veterinary Peptide Products Market Size by Application
8.3.1 China Veterinary Peptide Products Market Size by Application (2018-2023)
8.3.2 China Veterinary Peptide Products Market Size by Application (2024-2033)
8.3.3 China Veterinary Peptide Products Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Veterinary Peptide Products Market Size (2018-2033)
9.2 Asia Veterinary Peptide Products Market Size by Type
9.2.1 Asia Veterinary Peptide Products Market Size by Type (2018-2023)
9.2.2 Asia Veterinary Peptide Products Market Size by Type (2024-2033)
9.2.3 Asia Veterinary Peptide Products Market Share by Type (2018-2033)
9.3 Asia Veterinary Peptide Products Market Size by Application
9.3.1 Asia Veterinary Peptide Products Market Size by Application (2018-2023)
9.3.2 Asia Veterinary Peptide Products Market Size by Application (2024-2033)
9.3.3 Asia Veterinary Peptide Products Market Share by Application (2018-2033)
9.4 Asia Veterinary Peptide Products Market Size by Region
9.4.1 Asia Veterinary Peptide Products Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Veterinary Peptide Products Market Size by Region (2018-2023)
9.4.3 Asia Veterinary Peptide Products Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Type
10.2.1 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Veterinary Peptide Products Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Application
10.3.1 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Veterinary Peptide Products Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Country
10.4.1 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AmbioPharm
11.1.1 AmbioPharm Company Details
11.1.2 AmbioPharm Business Overview
11.1.3 AmbioPharm Veterinary Peptide Products Introduction
11.1.4 AmbioPharm Revenue in Veterinary Peptide Products Business (2018-2023)
11.1.5 AmbioPharm Recent Developments
11.2 Zoetis
11.2.1 Zoetis Company Details
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Veterinary Peptide Products Introduction
11.2.4 Zoetis Revenue in Veterinary Peptide Products Business (2018-2023)
11.2.5 Zoetis Recent Developments
11.3 Ceva Corporate
11.3.1 Ceva Corporate Company Details
11.3.2 Ceva Corporate Business Overview
11.3.3 Ceva Corporate Veterinary Peptide Products Introduction
11.3.4 Ceva Corporate Revenue in Veterinary Peptide Products Business (2018-2023)
11.3.5 Ceva Corporate Recent Developments
11.4 Huvepharma
11.4.1 Huvepharma Company Details
11.4.2 Huvepharma Business Overview
11.4.3 Huvepharma Veterinary Peptide Products Introduction
11.4.4 Huvepharma Revenue in Veterinary Peptide Products Business (2018-2023)
11.4.5 Huvepharma Recent Developments
11.5 Lifecome Biochemistry
11.5.1 Lifecome Biochemistry Company Details
11.5.2 Lifecome Biochemistry Business Overview
11.5.3 Lifecome Biochemistry Veterinary Peptide Products Introduction
11.5.4 Lifecome Biochemistry Revenue in Veterinary Peptide Products Business (2018-2023)
11.5.5 Lifecome Biochemistry Recent Developments
11.6 Qilu Pharmaceutical
11.6.1 Qilu Pharmaceutical Company Details
11.6.2 Qilu Pharmaceutical Business Overview
11.6.3 Qilu Pharmaceutical Veterinary Peptide Products Introduction
11.6.4 Qilu Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023)
11.6.5 Qilu Pharmaceutical Recent Developments
11.7 Orion Animal Nutrition
11.7.1 Orion Animal Nutrition Company Details
11.7.2 Orion Animal Nutrition Business Overview
11.7.3 Orion Animal Nutrition Veterinary Peptide Products Introduction
11.7.4 Orion Animal Nutrition Revenue in Veterinary Peptide Products Business (2018-2023)
11.7.5 Orion Animal Nutrition Recent Developments
11.8 Vega Pharma
11.8.1 Vega Pharma Company Details
11.8.2 Vega Pharma Business Overview
11.8.3 Vega Pharma Veterinary Peptide Products Introduction
11.8.4 Vega Pharma Revenue in Veterinary Peptide Products Business (2018-2023)
11.8.5 Vega Pharma Recent Developments
11.9 Tianjin Xinxing Veterinary Pharmaceutical
11.9.1 Tianjin Xinxing Veterinary Pharmaceutical Company Details
11.9.2 Tianjin Xinxing Veterinary Pharmaceutical Business Overview
11.9.3 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Introduction
11.9.4 Tianjin Xinxing Veterinary Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023)
11.9.5 Tianjin Xinxing Veterinary Pharmaceutical Recent Developments
11.10 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
11.10.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Company Details
11.10.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
11.10.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Introduction
11.10.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Revenue in Veterinary Peptide Products Business (2018-2023)
11.10.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Veterinary Peptide Products Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Oxytocin
Table 3. Key Players of Gonadorelin
Table 4. Key Players of Buserelin
Table 5. Key Players of Veterinary Bacitracin Zinc
Table 6. Key Players of Others
Table 7. Global Veterinary Peptide Products Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Veterinary Peptide Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Veterinary Peptide Products Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Veterinary Peptide Products Market Share by Region (2018-2023)
Table 11. Global Veterinary Peptide Products Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Veterinary Peptide Products Market Share by Region (2024-2033)
Table 13. Veterinary Peptide Products Market Trends
Table 14. Veterinary Peptide Products Market Drivers
Table 15. Veterinary Peptide Products Market Challenges
Table 16. Veterinary Peptide Products Market Restraints
Table 17. Global Veterinary Peptide Products Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Veterinary Peptide Products Revenue Share by Players (2018-2023)
Table 19. Global Top Veterinary Peptide Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Peptide Products as of 2022)
Table 20. Global Veterinary Peptide Products Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Veterinary Peptide Products Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Veterinary Peptide Products, Headquarters and Area Served
Table 23. Global Key Players of Veterinary Peptide Products, Product and Application
Table 24. Global Key Players of Veterinary Peptide Products, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Veterinary Peptide Products Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Veterinary Peptide Products Revenue Market Share by Type (2018-2023)
Table 28. Global Veterinary Peptide Products Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Veterinary Peptide Products Revenue Market Share by Type (2024-2033)
Table 30. Global Veterinary Peptide Products Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Veterinary Peptide Products Revenue Share by Application (2018-2023)
Table 32. Global Veterinary Peptide Products Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Veterinary Peptide Products Revenue Share by Application (2024-2033)
Table 34. North America Veterinary Peptide Products Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Veterinary Peptide Products Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Veterinary Peptide Products Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Veterinary Peptide Products Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Veterinary Peptide Products Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Veterinary Peptide Products Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Veterinary Peptide Products Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Veterinary Peptide Products Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Veterinary Peptide Products Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Veterinary Peptide Products Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Veterinary Peptide Products Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Veterinary Peptide Products Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Veterinary Peptide Products Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Veterinary Peptide Products Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Veterinary Peptide Products Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Veterinary Peptide Products Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Veterinary Peptide Products Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Veterinary Peptide Products Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Veterinary Peptide Products Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Veterinary Peptide Products Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Veterinary Peptide Products Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Veterinary Peptide Products Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Veterinary Peptide Products Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Veterinary Peptide Products Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Veterinary Peptide Products Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Veterinary Peptide Products Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Veterinary Peptide Products Market Size by Country (2024-2033) & (US$ Million)
Table 66. AmbioPharm Company Details
Table 67. AmbioPharm Business Overview
Table 68. AmbioPharm Veterinary Peptide Products Product
Table 69. AmbioPharm Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 70. AmbioPharm Recent Developments
Table 71. Zoetis Company Details
Table 72. Zoetis Business Overview
Table 73. Zoetis Veterinary Peptide Products Product
Table 74. Zoetis Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 75. Zoetis Recent Developments
Table 76. Ceva Corporate Company Details
Table 77. Ceva Corporate Business Overview
Table 78. Ceva Corporate Veterinary Peptide Products Product
Table 79. Ceva Corporate Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 80. Ceva Corporate Recent Developments
Table 81. Huvepharma Company Details
Table 82. Huvepharma Business Overview
Table 83. Huvepharma Veterinary Peptide Products Product
Table 84. Huvepharma Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 85. Huvepharma Recent Developments
Table 86. Lifecome Biochemistry Company Details
Table 87. Lifecome Biochemistry Business Overview
Table 88. Lifecome Biochemistry Veterinary Peptide Products Product
Table 89. Lifecome Biochemistry Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 90. Lifecome Biochemistry Recent Developments
Table 91. Qilu Pharmaceutical Company Details
Table 92. Qilu Pharmaceutical Business Overview
Table 93. Qilu Pharmaceutical Veterinary Peptide Products Product
Table 94. Qilu Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 95. Qilu Pharmaceutical Recent Developments
Table 96. Orion Animal Nutrition Company Details
Table 97. Orion Animal Nutrition Business Overview
Table 98. Orion Animal Nutrition Veterinary Peptide Products Product
Table 99. Orion Animal Nutrition Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 100. Orion Animal Nutrition Recent Developments
Table 101. Vega Pharma Company Details
Table 102. Vega Pharma Business Overview
Table 103. Vega Pharma Veterinary Peptide Products Product
Table 104. Vega Pharma Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 105. Vega Pharma Recent Developments
Table 106. Tianjin Xinxing Veterinary Pharmaceutical Company Details
Table 107. Tianjin Xinxing Veterinary Pharmaceutical Business Overview
Table 108. Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Product
Table 109. Tianjin Xinxing Veterinary Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 110. Tianjin Xinxing Veterinary Pharmaceutical Recent Developments
Table 111. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Company Details
Table 112. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
Table 113. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Product
Table 114. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 115. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Peptide Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Veterinary Peptide Products Market Share by Type: 2022 VS 2033
Figure 3. Oxytocin Features
Figure 4. Gonadorelin Features
Figure 5. Buserelin Features
Figure 6. Veterinary Bacitracin Zinc Features
Figure 7. Others Features
Figure 8. Global Veterinary Peptide Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Veterinary Peptide Products Market Share by Application: 2022 VS 2033
Figure 10. Pig Case Studies
Figure 11. Ox Case Studies
Figure 12. Sheep Case Studies
Figure 13. Others Case Studies
Figure 14. Veterinary Peptide Products Report Years Considered
Figure 15. Global Veterinary Peptide Products Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Veterinary Peptide Products Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Veterinary Peptide Products Market Share by Region: 2022 VS 2033
Figure 18. Global Veterinary Peptide Products Market Share by Players in 2022
Figure 19. Global Top Veterinary Peptide Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Peptide Products as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Veterinary Peptide Products Revenue in 2022
Figure 21. North America Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Veterinary Peptide Products Market Share by Type (2018-2033)
Figure 23. North America Veterinary Peptide Products Market Share by Application (2018-2033)
Figure 24. North America Veterinary Peptide Products Market Share by Country (2018-2033)
Figure 25. United States Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Veterinary Peptide Products Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Veterinary Peptide Products Market Share by Type (2018-2033)
Figure 29. Europe Veterinary Peptide Products Market Share by Application (2018-2033)
Figure 30. Europe Veterinary Peptide Products Market Share by Country (2018-2033)
Figure 31. Germany Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Veterinary Peptide Products Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Veterinary Peptide Products Market Share by Type (2018-2033)
Figure 39. China Veterinary Peptide Products Market Share by Application (2018-2033)
Figure 40. Asia Veterinary Peptide Products Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Veterinary Peptide Products Market Share by Type (2018-2033)
Figure 42. Asia Veterinary Peptide Products Market Share by Application (2018-2033)
Figure 43. Asia Veterinary Peptide Products Market Share by Region (2018-2033)
Figure 44. Japan Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Veterinary Peptide Products Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Veterinary Peptide Products Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Veterinary Peptide Products Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Veterinary Peptide Products Market Share by Country (2018-2033)
Figure 54. Brazil Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. AmbioPharm Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 61. Zoetis Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 62. Ceva Corporate Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 63. Huvepharma Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 64. Lifecome Biochemistry Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 65. Qilu Pharmaceutical Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 66. Orion Animal Nutrition Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 67. Vega Pharma Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 68. Tianjin Xinxing Veterinary Pharmaceutical Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 69. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed